This podcast series covers various facets of the growing cannabis market, including legal and regulatory developments, innovative technologies, business opportunities, market research, and trends. Hosted by experts, entrepreneurs, and industry leaders, the podcast provides valuable insights and advice for those involved in or interested in the cannabis industry. It serves as an information source and knowledge-sharing platform to help professionals and enthusiasts navigate this emerging and evolving field.
The new CanG of Germany is causing a stir: Who are the winners, who are the losers, and what needs urgent revision?
As of April 1, 2024, Germany has decriminalized cannabis: possession, consumption, and personal cultivation are now penalty-free. Starting July 1, 2024, cultivation associations (colloquially known as "CSCs, Cannabis Social Clubs") are allowed to cultivate cannabis for up to 500 members and distribute it to their members non-profitably. Additionally, medical cannabis is no longer subject to the Narcotics Act and can now be prescribed by any doctor without the need for Btmg paperwork. What do these changes mean for Germany? Where are revisions urgently needed? And what are the chances for Phase 2, where model projects similar to Swiss pilot projects are planned?
Moderator
Moritz Förster
Speakers
Dirk Heitepriem
Finn Hänsel
Olivia Ewenike
Dr. Philipp Goebel
Timo Bongartz
3 Jul 2024
Deep Dive into German Cultivation Associations: What does it take to establish and successfully operate a cultivation association?
As of July 1, 2024, cultivation associations are allowed to grow cannabis for their up to 500 members and sell it to them without profit. As the "closing panels" of the preceding Intensive Seminar for Cultivation Associations (Cannabis Competence Days, CKT, Wednesday, June 12 – Thursday, June 13), experts from the fields of law, marketing, competition, and cultivation technology delve into the challenges posed by this law. What does it take to establish a cultivation association, grow high-quality cannabis, and distribute it successfully?
Moderator
Dirk Rehahn
Speakers
Marcus Geschwandter
Christian Schmitt
Marc Montandon
Martin Anker
Jörg Löser
3 Jul 2024
Medical Cannabis is no longer a Narcotic in Germany: What impact does the new legislation have on the market and the involved stakeholders?
With the new CanG, Germany has removed medical cannabis from the narcotics list. Doctors can now prescribe cannabis to patients without extensive bureaucratic hurdles, and at the same time, the cultivation of medical cannabis in Germany is permitted. What impact does this have on the market regarding prescription numbers for private and insured patients? How do patients benefit from this? What do doctors and pharmacies say about the new legislation?
Moderator
Garvin Hirt
Speakers
Leif Burmeister
Christiane Neubaur
Marcus Reussmann
Nicole Perenyi
Contact CB Company
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of CB Company?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
